Intradermal vaccination of pigs against FMD with 1/10 dose results in comparable vaccine efficacy as intramuscular vaccination with a full dose

Vaccine

Volumn 27, Issue 8, 2009, Pages 1272-1278

  Eble P L ^a   Weerdmeester, K ^a   van Hemert Kluitenberg, F ^a   Dekker, A ^a  

^a WAGENINGEN UNIVERSITY   (Netherlands)

Author keywords

FMDV; Foot and mouth disease; Intradermal; Pigs; Vaccination

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN M;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; DRUG COST; DRUG DOSE COMPARISON; DRUG EFFICACY; FOOT AND MOUTH DISEASE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; VACCINATION; VETERINARY MEDICINE; VIRUS ISOLATION; VIRUS RESISTANCE;

ANIMALS; ANTIBODIES, VIRAL; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; INJECTIONS, INTRADERMAL; INJECTIONS, INTRAMUSCULAR; NEUTRALIZATION TESTS; SEVERITY OF ILLNESS INDEX; SWINE; SWINE DISEASES; VIRAL VACCINES; VIRUS SHEDDING;

EID: 58749094253     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.12.011     Document Type: Article

References (28)

1. Anonymous. Chapter 2.2.10. Foot and mouth disease. In: OIE terrestrial animal health code, 15th ed. Office International des Epizooties (Paris, France), 2005. Article 2.2.10.7. www.oie.int.
2. Anonymous. Council Directive 2003/85/EC. Official Journal of the European Union 2003;46:L306. www.europa.eu.int.
3. Glenn G.M., and Kenney R.T. Mass vaccination: solutions in the skin. Curr Top Microbiol Immunol 304 (2006) 247-268
4. Visser N., Egger W., and Lutticken D. Intradermal application of Aujeszky's disease virus strain Begonia with tocopherol-based adjuvant and a novel design injection device. Acta Vet Hung 42 2-3 (1994) 413-418
5. Martelli P., Cordioli P., Alborali L.G., Gozio S., De Angelis E., Ferrari L., et al. Protection and immune response in pigs intradermally vaccinated against porcine reproductive and respiratory syndrome (PRRS) and subsequently exposed to a heterologous European (Italian cluster) field strain. Vaccine 25 17 (2007) 3400-3408
6. De Leeuw P.W., Tiessink J.W.A., and Frenkel S. Vaccination of pigs with formaldehyde-inactivated aluminium hydroxide foot-and-mouth disease vaccines, potentiated with diethylaminoethyldextran (DEAE-D). Zentralbl Veterinarmed B 26 (1979) 85-97
7. Moonen P.L.J.M., Boonstra J., Hakze-van der Honing R.W., Boonstra-Leendertse C.H., Jacobs C.E., and Dekker A. Validation of a LightCycler based reverse transcription polymerase chain reaction for the detection of foot-and-mouth disease virus in an outbreak situation. J Virol Methods 113 1 (2003) 35-41
8. Eble P.L., Bouma A., Weerdmeester K., Stegeman J.A., and Dekker A. Serological and mucosal immune responses after vaccination and infection with FMDV in pigs. Vaccine 25 6 (2007) 1043-1054
9. Hunsaker B.D., and Perino L.J. Efficacy of intradermal vaccination. Vet Immunol Immunopathol 79 1-2 (2001) 1-13
10. Vanderpooten A., Goddeeris B., De Roose P., Hendrickx L., Biront P., and Desmettre P. Evaluation of parenteral vaccination methods with glycoproteins against Aujeszky's disease in pigs. Vet Microbiol 55 1-4 (1997) 81-89
11. Vannier P., and Cariolet R. Vaccination of pigs against Aujeszky's disease by the intradermal route using live attenuated and inactivated virus vaccines. Vet Microbiol 26 1-2 (1991) 11-23
12. Mikulska-Skupien E., Szweda W., Procajlo Z., and Platt-Samoraj A. Indices of non-specific cellular immune response in pigs after intradermal vaccination with deleted Aujeszky's disease vaccine and after experimental infection. Bull Vet Inst Pulawy 48 4 (2004) 347-354
13. Auewarakul P., Kositanont U., Sornsathapornkul P., Tothong P., Kanyok R., and Thongcharoen P. Antibody responses after dose-sparing intradermal influenza vaccination. Vaccine 25 4 (2007) 659-663
14. Kenney R.T., Frech S.A., Muenz L.R., Villar C.P., and Glenn G.M. Dose sparing with intradermal injection of influenza vaccine. N Engl J Med 351 22 (2004) 2295-2301
15. Belshe R.B., Newman F.K., Cannon J., Duane C., Treanor J., Van Hoecke C., et al. Serum antibody responses after intradermal vaccination against influenza. N Engl J Med 351 22 (2004) 2286-2294
16. Warrell M.J., Nicholson K.G., Warrell D.A., Suntharasamai P., Chanthavanich P., Viravan C., et al. Economical multiple-site intradermal immunisation with human diploid-cell-strain vaccine is effective for post-exposure rabies prophylaxis. Lancet 1 8437 (1985) 1059-1062
17. Warrell M.J., Riddell A., Yu L.M., Phipps J., Diggle L., Bourhy H., et al. A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods. PLoS Negl Trop Dis 2 4 (2008) e224
18. Chutivongse S., Wilde H., Supich C., Baer G.M., and Fishbein D.B. Postexposure prophylaxis for rabies with antiserum and intradermal vaccination. Lancet 335 8694 (1990) 896-898
19. Karahocagil M.K., Buzgan T., Irmak H., Karsen H., Akdeniz H., and Akman N. Comparison of intramuscular and intradermal applications of hepatitis B vaccine in hemodialysis patients. Renal Failure 28 7 (2006) 561-565
20. Sangfelt P., Uhnoo I., Reichard O., and Weiland O. A low-dose intradermal hepatitis B vaccine programme in health-care workers and students is highly effective and cost saving: a retrospective follow-up survey in the clinical setting. Scand J Gastroenterol 43 4 (2008) 465-472
21. Cox S.J., Voyce C., Parida S., Reid S.M., Hamblin P.A., Hutchings G., Paton D.J., and Barnett P.V. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle. Vaccine 24 16 (2006) 3184-3190
22. Barnett P.V., Keel P., Reid S., Armstrong R.M., Statham R.J., Voyce C., Aggarwal N., and Cox S.J. Evidence that high potency foot-and-mouth disease vaccine inhibits local virus replication and prevents the "carrier" state in sheep. Vaccine 22 9-10 (2004) 1221-1232
23. World Health Organization. Weekly epidemiological record. Rabies vaccines WHO position paper. 2007;82(49/50):425-36, http://www.who.int/wer/2007/wer8249_50.pdf.
24. Pay T.W., and Hingley P.J. Correlation of 140S antigen dose with the serum neutralising antibody response and the level of protection induced in cattle by foot-and-mouth disease vaccines. Vaccine 5 1 (1987) 60-64
25. Belyakov I.M., Hammond S.A., Ahlers J.D., Glenn G.M., and Berzofsky J.A. Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells. J Clin Invest 113 7 (2004) 998-1007
26. Rahman F, Dahmen A, Herzog-Hauff S, Bocher WO, Galle PR, Lohr HF. Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with the major hepatitis B surface antigen. Hepatology 2000;31(2):521-7.
27. Vogt A., Mahe B., Costagliola D., Bonduelle O., Hadam S., Schaefer G., et al. Transcutaneous anti-influenza vaccination promotes both CD4 and CD8 T cell immune responses in humans. J Immunol 180 3 (2008) 1482-1489
28. Launay O., Durier C., Desaint C., Silbermann B., Jackson A., Pialoux G., et al. Cellular immune responses induced with dose-sparing intradermal administration of HIV vaccine to HIV-uninfected volunteers in the ANRS VAC16 trial. PLoS ONE 2 1 (2007) e725